See also this year's filing and all EDGAR filings for this company.
PDF Report 0001583771_2023_Hepion_Pharmaceuticals_Inc.pdf
Logs
info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001583771, Hepion Pharmaceuticals Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 56,496,073 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 81,620 |
3 | remainder_Assets | 3,666,759 |
4 | LiabilitiesCurrent | 7,885,722 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 2,502,793 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 10,348,465 |
9 | ResearchAndDevelopmentExpense | 33,269,337 |
10 | remainder_Expenses | -1,002,761 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 414,992 |
13 | remainder_ComprehensiveNetIncome | -90,168 |
yvar | yval | |
---|---|---|
0 | Assets | 60,244,452 |
1 | Liabilities | 10,388,515 |
2 | Expenses | 42,615,041 |
3 | Revenues | 0 |
4 | StockholdersEquity | 49,855,937 |
5 | NetIncome | -42,200,049 |
6 | ComprehensiveNetIncome | -42,245,133 |
7 | BaseVar | 56,876,584 |
8 | EconomicCapitalRatio | 1.23 |